Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market today that its third quarter revenues were up seven percent year over year.

For the three months ended Sept. 30, NanoString's revenues were $30.6 million compared to $28.6 million in Q3 2018, beating the Wall Street estimate of $28.1 million.

The firm said it took in $26.3 million in product and service revenue in the quarter, a 23 percent increase from $21.5 million in Q3 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.